endrainc.com (NDRA) - מזומנים למניה

סמל תאגידי ולוגו של ENDRA Corp (NDRA)

Cash per share demonstrates how the TAEUS platform is being integrated into routine screenings for the early detection of steatosis. Stable equipment deliveries via a network of contract manufacturers support growth, while strong pricing power in diagnostics strengthens the position of ENDRA Life Sciences (NDRA). The latest figure stands at 3.31, allowing for a real-time assessment of capital inflows and the issuer's financial autonomy.

ENDRA Life Sciences Inc (NDRA) - יתרות מזומנים למניה מ-04.07.2022 עד 20.11.2026

פילוחי מדדים מקיפים ואנליטיקה עבור ENDRA Life Sciences (NDRA)

- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח מסכם של החברה:NDRA (ENDRA Life Sciences)
מוצר המיוצר על ידי ENDRA Corp

This metric is calculated as the ratio of total free cash flow to the number of shares outstanding. The metric determines the level of internal liquidity and the business's ability to withstand inflationary risks without external borrowing. For ENDRA Life Sciences (NDRA), excess cash facilitates the expansion of unique ultrasound sensors with minimal production costs. However, stagnant funds reduce overall capital efficiency. By analyzing this chart of cash reserves per share, an investor can promptly identify a turning point in resource accumulation.